F60. INFLAMMATORY MARKERS AND COGNITIVE PERFORMANCE IN PATIENTS WITH SCHIZOPHRENIA TREATED WITH LURASIDONE

BACKGROUND: Recent studies have linked inflammation, obesity, and lipid dysregulation with cognitive impairment, a core feature of schizophrenia. Elevated C-reactive protein concentration has been shown to be a reliable biomarker for inflammatory states. We conducted an exploratory analysis to inves...

Descripción completa

Detalles Bibliográficos
Autores principales: Pikalov, Andrei, Miller, Brian, Siu, Cynthia, Tocco, Michael, Tsai, Joyce, Harvey, Philip, Loebel, Antony
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5888792/
http://dx.doi.org/10.1093/schbul/sby017.591

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5888792/
http://dx.doi.org/10.1093/schbul/sby017.591

Ejemplares similares